The National Department of Health is introducing a new drug, Dolutegravir (DTG), in combination with Tenofovir (TDF) and Lamivudine (3TC). The combination of TDF/3TC/DTG is known as TLD. The objectives of this training are to:
SETTING: Recent evidence indicates that human immunodeficiency virus (HIV) and tuberculosis (TB) related stigma act as a key barrier to the utilisation of associated occupational health services by South African health care workers (HCWs).
These guidelines are intended as a reference document to assist HIV nurse and doctor clinicians in managing mental health disorders. It is intended to improve awareness, knowledge and capacity to support patients living with HIV and mental health disorders.